CNS Pharmaceuticals, Inc. has filed an IPO in the amount of $10.625 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 2,125,000
PriceRange: $4 to $5
Discount Per Security: $0.35
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2006 USD | -1.67% | -0.69% | -84.20% |
Apr. 23 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
Apr. 01 | CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-84.20% | 2.17M | |
+1.91% | 42.59B | |
+7.45% | 40.65B | |
+49.22% | 40.57B | |
-11.96% | 26.77B | |
+9.26% | 24.81B | |
-24.10% | 18.17B | |
+27.28% | 12.05B | |
-3.35% | 11.7B | |
+6.64% | 11.1B |